Page last updated: 2024-09-04

asenapine and Behavior Disorders

asenapine has been researched along with Behavior Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Guan, S; Ma, Y; Wang, YE; Zhai, J; Zhou, X1
Koht, J; Solberg, M1
Carrothers, TJ; de Greef, R; Dennie, J; Dogterom, P; Findling, RL; Jakate, A; Johnson, M; Miltenburg, AM; Pilla Reddy, V; Riesenberg, R; Troyer, MD1
Maina, G; Ripellino, C1

Trials

1 trial(s) available for asenapine and Behavior Disorders

ArticleYear
Asenapine pharmacokinetics and tolerability in a pediatric population.
    Drug design, development and therapy, 2018, Volume: 12

    Topics: Adolescent; Antipsychotic Agents; Child; Dibenzocycloheptenes; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mental Disorders

2018

Other Studies

3 other study(ies) available for asenapine and Behavior Disorders

ArticleYear
Long-term sustained release Poly(lactic-co-glycolic acid) microspheres of asenapine maleate with improved bioavailability for chronic neuropsychiatric diseases.
    Drug delivery, 2020, Volume: 27, Issue:1

    Topics: Animals; Antipsychotic Agents; Biocompatible Materials; Biological Availability; Delayed-Action Preparations; Dibenzocycloheptenes; Dogs; Humans; Mental Disorders; Microfluidics; Microspheres; Polylactic Acid-Polyglycolic Acid Copolymer; Time Factors; X-Ray Diffraction

2020
Oculogyric Crises.
    Tremor and other hyperkinetic movements (New York, N.Y.), 2017, Volume: 7

    Topics: Antipsychotic Agents; Dibenzocycloheptenes; Dystonic Disorders; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mental Disorders; Ocular Motility Disorders; Quetiapine Fumarate; Young Adult

2017
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain.
    Expert opinion on drug safety, 2014, Volume: 13, Issue:9

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Diabetes Mellitus, Type 2; Dibenzocycloheptenes; Dyslipidemias; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Italy; Male; Mental Disorders; Middle Aged; Olanzapine; Retrospective Studies; Spain

2014